Avalon Globocare CORP Form 4 insider transactions

Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.

NASDAQ
Michael Mathews, a Director of Avalon GloboCare Corp., reported multiple transactions in common stock on August 5, 2026.
NASDAQ
Wenzhao Lu, a Director of Avalon GloboCare Corp., received 200,000 shares of common stock on June 29, 2026.
NASDAQ
Steven Andrew Sanders, a Director of Avalon GloboCare Corp., received 200,000 shares of common stock on June 29, 2026.
NASDAQ
Michael Mathews, a Director of Avalon GloboCare Corp., received 100,000 shares of common stock on June 29, 2026.
NASDAQ
Meng Li, Interim CEO of Avalon GloboCare Corp., received 400,000 shares of common stock on June 29, 2026.
NASDAQ
Luisa Ingargiola, Chief Strategy Officer of Avalon GloboCare Corp., received 400,000 shares of common stock on June 29, 2026.
NASDAQ
Lourdes Felix, a Director of Avalon GloboCare Corp., received 100,000 shares of common stock on June 29, 2026.
NASDAQ
Avalon GloboCare Corp. director Michael Mathews acquired Series E Non-Voting Convertible Preferred Stock convertible into 909,894 common shares as part of the RPM Interactive acquisition.
NASDAQ
Avalon GloboCare Corp. provides an investor presentation detailing its proposed merger with YOOV Group Holding Limited and YOOV's strong preliminary financial performance.
NASDAQ
Avalon GloboCare's subsidiary, Q&A Distribution, partners with Saga Health to distribute its KetoAir breathalyzer to first responders through a new wholesale agreement.
NASDAQ
Avalon GloboCare Corp. announced the issuance of a new 20-year patent in Hong Kong for its proprietary CAR-T and CAR-Natural Killer (NK) cell technology, enhancing its global intellectual property portfolio.
NASDAQ
Avalon GloboCare and Qi Diagnostics have entered a definitive agreement to co-develop a real-time cannabis breathalyzer for impaired driving detection.
NASDAQ
Avalon GloboCare and YOOV Group have jointly announced the filing of a registration statement for their proposed merger, aiming to create a publicly-traded company focused on AI-as-a-Service solutions.
NASDAQ
Avalon GloboCare Corp. and YOOV Group Holding Limited have entered into a definitive merger agreement, with the combined entity expected to operate as YOOV, Inc. and trade on the Nasdaq Capital Market under the ticker symbol 'YOOV'.